Company StemCell Institute Inc.

Equities

7096

JP3399640006

Healthcare Facilities & Services

Delayed Japan Exchange 02:00:00 2024-05-29 EDT 5-day change 1st Jan Change
1,649 JPY -2.14% Intraday chart for StemCell Institute Inc. -6.89% -23.09%

Business Summary

StemCell Institute Inc is mainly engaged in the cell bank business, which separates and stores cord blood. The Company operates cell bank business from umbilical cord blood and umbilical cord, development of new treatment methods and regenerative medicine products, regenerative medicine and fertility treatment, business development and investment in childbirth and childcare areas. The Company operates Cell Bank business segment. After signing the contract for the separation and storage of umbilical cord blood with customers (pregnant women), the umbilical cord blood collected at domestic umbilical cord blood collection cooperative hospitals (university hospitals, obstetric clinics and others) is collected, and carried into its cell processing center in Minato-ku, Tokyo and Midori-ku, Yokohama. It is stored at its cell storage center (Midori-ku, Yokohama, Kanagawa) for a long time at ultra-low temperature after stem cells contained in cord blood being separated, extracted and prepared.

Number of employees: 92

Sales per Business

JPY in Million2022Weight2023Weight Delta
Technical Fee
79.0 %
1,354 76.0 % 1,651 79.0 % +21.99%
Storage Fee
17.3 %
322 18.1 % 361 17.3 % +12.13%
Others
3.8 %
106 6.0 % 79 3.8 % -25.81%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
1,782 100.0 % 2,091 100.0 % +17.36%

Managers

Managers TitleAgeSince
President 51 13-08-31
Chief Administrative Officer 53 16-05-31
Sales & Marketing - -
Comptroller/Controller/Auditor 77 99-05-31

Members of the board

Members of the board TitleAgeSince
President 51 13-08-31
Chief Administrative Officer 53 16-05-31
Director/Board Member 79 15-05-31
Comptroller/Controller/Auditor 77 99-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 10,246,600 2,288,354 ( 22.33 %) 46 ( 0.000449 %) 22.33 %

Shareholders

NameEquities%Valuation
7,384,200 72.06 % 88 M ¥
Nagoya Small & Medium Business Invst & Consultation Co., Ltd.
1.640 %
168,000 1.640 % 2 M ¥
124,600 1.216 % 1 M ¥
90,200 0.8803 % 1 M ¥
Sino Cell Technologies, Inc.
0.6832 %
70,000 0.6832 % 833 603 ¥
51,400 0.5016 % 612 103 ¥
Simplex Asset Management Co., Ltd.
0.3904 %
40,000 0.3904 % 476 345 ¥
Deutsche Asset Management (Japan) Ltd.
0.2479 %
25,400 0.2479 % 302 479 ¥
SBI Okasan Asset Management Co. Ltd.
0.0429 %
4,400 0.0429 % 52 398 ¥

Holdings

NameEquities%Valuation
100,000 1.26% 2,182,823 $
18,800 2.00% 165,940 $

Company contact information

StemCell Institute

5-22-10 Shinbashi Minato-Ku

105-0004, Tokyo

+

http://www.stemcell.co.jp
address StemCell Institute Inc.(7096)
  1. Stock Market
  2. Equities
  3. 7096 Stock
  4. Company StemCell Institute Inc.